Anisha Doshi

Neurology Consultant and Honorary postdoc research fellow at Queen Square MS Centre. Proud mum of 2! @QSMCentre @UCL @ION @DarentValleyHsp

[Anisha Doshi @AnishaDoshi]

A reminder to join us for the inaugural Cognition in MS special interest group meeting 31st Jan.

https://t.co/WDWxjBD6YM

@IntNatlWiMS @dr_sarahamorrow @HannekeHulst @laurenstrober

[OctopusTrial @OctopusTrial]

Read more and register your interest in taking part in the Octopus trial here: https://t.co/yMtXie2btM

[MS Society UK @mssocietyuk]

Today the results of the MS-STAT2 trial were announced by Professor Jeremy Chataway at the ECTRIMS research conference in Copenhagen.

This trial tested simvastatin, commonly used to treat high cholesterol, in 964 people with secondary progressive MS. (1/6)

[Aaron Boster MD @AaronBosterMD]

Serum neurofilament light and MRI predictors of cognitive decline in patients with secondary progressive multiple sclerosis: Analysis from the MS-STAT randomised controlled trial - PubMed https://t.co/VvO8N3b91b

[Neurology Academy @TheNeuroAcademy]

In case you missed our latest MS Academy webinar on Tuesday, this is now available to watch on our website: How do we define #cognitiveimpairment in #multiplesclerosis; current implications for clinical practice

@AnishaDoshi @MarkWebb_ @Florianadea
https://t.co/rNGivm6Fjp

[Nils Muhlert @nilsmuhlert]

New systematic review out with @dankajandric @AnishaDoshi @Mennoke @geoffjmparker and others showing that network connectivity changes in MS are cognitively relevant - but show both increases & decreases throughout the disease course https://t.co/A3xI2HllUi

[Anisha Doshi @AnishaDoshi]

Great to be part of the @ECTRIMS @imscogs summer school on #cognition in #ms. Such inspiring speakers and work… thank you for the opportunity

[Menno Schoonheim @Mennoke]

Today I spoke about insights from functional imaging into plasticity versus maladaptation in #MultipleSclerosis. Great to be on-site again after all this time! A lot of bright young clinicians and scientists in this wonderful @ECTRIMS @imscogs summerschool on #cognition in #MS.

[Anisha Doshi @AnishaDoshi]

Lovely to celebrate the PhD with colleagues in person! Thank you to my wonderful supervisors and mentors @olgacicc @QSMSCENTRE @MsStat2 @jchataway

[UCL Brain Sciences @UCLBrainScience]

Fantastic to see so many of our students at UCL’s in-person graduation ceremonies!

Here’s @UCLBrainScience Faculty Dean Prof Alan Thompson celebrating with #UCLBrainiacs Rosa, Floriana, Sara & Anisha at one of today's ceremonies 🎓🎉

#UCLBrainiacsGrad #UCLGrad

[Anisha Doshi @AnishaDoshi]

@jfdwolff Huge congratulations 🎉

[MS-STAT2 @MsStat2]

In case you thought Prof. Chataway wasn’t working hard enough on MS-STAT2! Lots more hope for new treatments in progressive MS through the OCTOPUS study 🐙 🐙 🐙 �� #stopMS
https://t.co/4rcT9Tvmx2

[QueenSquareMSCentre @QSMSCENTRE]

Ground-breaking new trial led by Prof Jeremy Chataway ⁦@UCLIoN⁩ ⁦@UCLBrainScience⁩ https://t.co/ThDXZoyIFw

[Dara Ó Briain @daraobriain]

If the government are planning to re-open schools in 3 weeks, shouldn’t we just vaccinate all teachers and school staff right now?

[MS-STAT2 @MsStat2]

Dear MS-STAT2 participants @UCLIoN : I’ve sent you all an email!

About time we had another zoom catch-up with the boss! Email me back and I’ll send you the invite link.

Prof. Chataway wants a cuppa tea and a chat to see how you’re all doing 🙌

[MS-STAT2 @MsStat2]

Not wanting to be outdone by @olgacicc , Prof Chataway gets in on the vaccinations as well!

Apparently @AnishaDoshi survived...
#CovidVaccine

[Danny Wong (黄永年) @dannyjnwong]

I'm exhausted. Been helping to transfer intubated patients around the hospital and resuscitate deteriorating patients on the ward in conjunction with colleagues from ICU. But there are still urgent and emergency operations taking place. Its relentless... Our ICUs are overflowing.

[Anisha Doshi @AnishaDoshi]

@MsStat2 @olgacicc “Don’t get Covid & get your minor corrections done”

[Neurology Academy @TheNeuroAcademy]

Shocking national shortfall in staffing calculated by audit and data workstream of over 100 neurologists, 200 nurses and 100 coordinators... #RtB4MS2020

[MS Society Scotland @mssocietyscot]

BREAKING NEWS | Siponimod, a new treatment for secondary progressive MS, has been approved for use on NHS Scotland.

It's the first oral treatment to be made available on the NHS in Scotland for secondary progressive MS.

[Anisha Doshi @AnishaDoshi]

@es_arman @GreenJournal @UCLIoN @QSMSCENTRE @UCLBrainScience Well done Arman!

[Anisha Doshi @AnishaDoshi]

@CarmenTur1 @GreenJournal Congratulations Carmen!